MedTrace Logo

PENG Block Versus LP Block for THA Postop Pain

NCT05261009 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2024-05-21

Study results available
· View outcomes & findings →

Summary

The purpose of this randomized, double blinded, prospective study is to compare the postoperative analgesia provided by the PENG block to that provided by the LPB for patients undergoing primary anterior approach THA.

Conditions

  • Pain, Postoperative
  • Hip Pain Chronic

Interventions

DRUG

Peri-capsular Nerve Group (PENG)

PENG block for postoperative pain management

OTHER

Lumbar Plexus Block (LPB)

LPB for postoperative pain management

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Rawad Hamzi, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-13
Primary Completion
2023-07-20
Completion
2023-07-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05261009 on ClinicalTrials.gov